| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Entasis Therapeutics Holdings Inc. | General Counsel | Common Stock | 0 | $2.20 | Jul 11, 2022 | Direct | |
| Entasis Therapeutics Holdings Inc. | General Counsel | Stock Option (right to buy) | 0 | Jul 11, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc. | Jul 7, 2022 | 4 | -$38.7K | 4 | Jul 11, 2022 | General Counsel |
| ETTX | Entasis Therapeutics Holdings Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 19, 2022 | General Counsel |
| ETTX | Entasis Therapeutics Holdings Inc. | Nov 2, 2021 | 1 | -$10.8K | 4 | Nov 3, 2021 | General Counsel |
| ETTX | Entasis Therapeutics Holdings Inc. | Oct 19, 2021 | 2 | -$12K | 4 | Oct 20, 2021 | General Counsel |
| ETTX | Entasis Therapeutics Holdings Inc. | Jul 16, 2021 | 2 | $0 | 4 | Feb 15, 2022 | General Counsel |